Form 4: Inari Medical Director Rebecca Chambers Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Director Rebecca Chambers reports acquiring 4,126 restricted stock units of Inari Medical at $42.41 per unit on April 24, 2024, and disposing of 10,908 common stock.
Summary
- On April 24, 2024, Rebecca Chambers, a director of Inari Medical, Inc., acquired 4,126 restricted stock units (RSUs) at a price of $42.41 per unit.
- These RSUs vest in full on the earlier of the day prior to Inari Medical's next annual meeting of stockholders or one year from the grant date.
- Following this transaction, Chambers directly owns 10,908 shares of Inari Medical common stock.
- Chambers also disposed of 10,908 common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency to investors regarding the actions of company leadership.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 04/24/2024 | Date of transaction: Rebecca Chambers acquired restricted stock units and disposed of common stock. |
| 04/26/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.